Opportunity timeline

PostedOct 27, 2026
DeadlineNov 2, 2026

In plain English

NINDS seeks a senior drug-development advisor with patient advocacy expertise to guide its Ultra-rare Gene-based Therapy Network. The work includes joining an external advisory board that may meet up to eight times a year, with occasional calls and a possible annual visit to the NIH campus. This is a small-business set-aside with a one-year base period and two option years, beginning November 6, 2026.

About this opportunity

COMBINED SYNOPSIS / SOLICITATION (COMPETITIVE) Title: Senior Advisor Subject Matter Expert (SME) with Patient Advocacy Expertise for the NINDS Ultra-rare Gene-based Therapy (URGenT) Network (i) This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with RFO Part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. The solicitation number is 7571PS27Q00015 issued as a Request for Quote for a Senior Advisor to act as a Subject Matter Expert (SME) with Patient Advocacy Expertise The Government reserves the right to make one award, multiple awards, or no…

Time remaining

Closes Nov 2, 2026

04Days
:
10Hours
:
47Min
:
16Sec

Related Opportunities

Bid details are gathered and summarized automatically. Please verify details at the original source.

Ref No.

BS-5E3D9A